Skip to content
DraconiticResearch
Search Sources API
203,948 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BY 4.0JAMA Network Open

Artificial Intelligence Use in Interventional Clinical Trials Registered on ClinicalTrials.gov

  • Selen Bozkurt1
  • Irem Kar1,2
  • Sweta Balaji1
  • Nevruz Ilhanli3
  • Selvi Ramalingam4
  • Azra Ismail1
  • Ravi B. Parikh5
5 affiliations
  1. 1Department of Biomedical Informatics, School of Medicine, Emory University, Atlanta, Georgia
  2. 2Department of Biostatistics, School of Medicine, Ankara University, Ankara, Turkiye
  3. 3Department of Biostatistics and Medical Informatics, School of Medicine, Akdeniz University, Antalya, Turkiye
  4. 4Emory Healthcare, Emory University, Atlanta, Georgia
  5. 5Department of Hematology and Medical Oncology, School of Medicine, Emory University, Atlanta, Georgia
Open at sourceDOICite

Abstract

This cross-sectional study examines the use of artificial intelligence (AI) in clinical trials conducted starting in 2022.

Related

  1. Representation of Surgery in Registered Clinical Trials for Brain Metastases: An Analysis of the ClinicalTrials.gov Database
    Sandra Leskinen, Nathan A. Shlobin, Roland A. Scott +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  2. Cancer prevention and interception studies registered in ClinicalTrials.gov: a landscape analysis of trial characteristics and reporting gaps.
    Martha Fors, Paloma González, Ariel Torres +2
    Frontiers in epidemiologyPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Factors influencing registered nurses’ attitudes toward and literacy in artificial intelligence: a cross-sectional systematic review
    Yingqi Dai, Xili Zhao, Xili Zhao +3
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthDOAJCrossrefEurope PMC
  4. Artificial Intelligence-Related Risks in Interventional Pulmonology: An Exploratory Enumeration and Ranking Study Across Five General-Purpose Large Language Models.
    Guido Marchi, Lorenzo Corbetta
    Journal of clinical medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  5. Low-Dose CT in the Age of Artificial Intelligence: Techniques, Evidence, and Clinical Impact
    TomographyPeer-reviewedCC BYFull textMedical imaging & radiologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{bozkurt2026artificial,
  title = {{Artificial Intelligence Use in Interventional Clinical Trials Registered on ClinicalTrials.gov}},
  author = {Selen Bozkurt and Irem Kar and Sweta Balaji and Nevruz Ilhanli and Selvi Ramalingam and Azra Ismail and Ravi B. Parikh},
  journal = {JAMA Network Open},
  year = {2026},
  month = nov,
  doi = {10.1001/jamanetworkopen.2026.42797},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856350},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Artificial Intelligence Use in Interventional Clinical Trials Registered on ClinicalTrials.gov
AU  - Selen Bozkurt
AU  - Irem Kar
AU  - Sweta Balaji
AU  - Nevruz Ilhanli
AU  - Selvi Ramalingam
AU  - Azra Ismail
AU  - Ravi B. Parikh
PY  - 2026
DA  - 2026/11/09
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.42797
UR  - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2856350
AB  - This cross-sectional study examines the use of artificial intelligence (AI) in clinical trials conducted starting in 2022.
SN  - 2574-3805
ER  -